Group 1 - Walt Disney's stock closed at $83.30, reflecting a -0.28% change, underperforming the S&P 500's daily loss of 0.23% [1] - Over the past month, Walt Disney shares have decreased by 20.83%, compared to a 19.11% loss in the Consumer Discretionary sector and a 12.13% loss in the S&P 500 [1] Group 2 - The upcoming earnings report for Walt Disney is scheduled for May 7, 2025, with projected earnings per share (EPS) of $1.19, indicating a 1.65% decrease year-over-year [2] - The Zacks Consensus Estimate for revenue is $23.19 billion, representing a 5.03% increase from the previous year [2] Group 3 - For the annual period, the Zacks Consensus Estimates predict earnings of $5.48 per share and revenue of $94.63 billion, reflecting increases of +10.26% and +3.58% respectively from the last year [3] - Recent changes in analyst estimates for Walt Disney are important as they indicate evolving short-term business trends, with positive revisions suggesting a favorable outlook on the company's health and profitability [3][4] Group 4 - The Zacks Rank system, which ranges from 1 (Strong Buy) to 5 (Strong Sell), indicates that Walt Disney currently holds a Zacks Rank of 3 (Hold) [5] - The Zacks Consensus EPS estimate has decreased by 0.04% in the past month [5] Group 5 - Walt Disney's Forward P/E ratio is 15.25, which is lower than the industry average of 16.45 [5] - The company has a PEG ratio of 1.36, compared to the Media Conglomerates industry's average PEG ratio of 1.7 [6] Group 6 - The Media Conglomerates industry, part of the Consumer Discretionary sector, has a Zacks Industry Rank of 175, placing it in the bottom 30% of over 250 industries [6][7] - Research indicates that the top 50% rated industries outperform the bottom half by a factor of 2 to 1 [7]

Company Performance - JPMorgan Chase & Co. closed at $214.05, reflecting a +1.79% increase from the previous day, outperforming the S&P 500 which fell by 0.23% [1] - Over the past month, JPMorgan's shares have decreased by 13.21%, which is worse than the Finance sector's decline of 9.66% and the S&P 500's drop of 12.13% [1] Upcoming Earnings - The company's earnings report is scheduled for April 11, 2025, with an expected EPS of $4.62, indicating a 0.22% decrease from the same quarter last year [2] - Revenue is projected to be $43.03 billion, representing a 2.6% increase from the prior-year quarter [2] Fiscal Year Projections - For the entire fiscal year, earnings are estimated at $18.04 per share and revenue at $172.88 billion, reflecting changes of -8.66% and -2.64% respectively from the previous year [3] Analyst Estimates - Recent modifications to analyst estimates for JPMorgan are crucial as they reflect near-term business trends, with positive revisions indicating optimism about the company's outlook [4] - The Zacks Rank system, which incorporates estimate changes, currently ranks JPMorgan at 3 (Hold) [6] Valuation Metrics - JPMorgan is trading at a Forward P/E ratio of 11.66, which is below the industry average of 11.8 [7] - The company has a PEG ratio of 2.42, compared to the Financial - Investment Bank industry's average PEG ratio of 0.95 [7] Industry Context - The Financial - Investment Bank industry, part of the Finance sector, holds a Zacks Industry Rank of 68, placing it in the top 28% of over 250 industries [8] - Research indicates that the top 50% rated industries outperform the bottom half by a factor of 2 to 1 [8]

Group 1: Company Performance - Visa's stock closed at $311.85, reflecting a -0.41% change from the previous day's closing price, underperforming the S&P 500's loss of 0.23% [1] - Over the past month, Visa's shares have decreased by 9.32%, which is better than the Business Services sector's loss of 10.29% and the S&P 500's loss of 12.13% [1] Group 2: Earnings Projections - Analysts project Visa's earnings per share (EPS) to be $2.68, indicating a 6.77% increase from the same quarter last year, with revenue expected to reach $9.56 billion, an 8.91% increase year-over-year [2] - For the entire fiscal year, earnings are projected at $11.31 per share and revenue at $39.58 billion, representing increases of +12.54% and +10.17% respectively from the prior year [3] Group 3: Analyst Forecasts and Valuation - Recent revisions to analyst forecasts for Visa are important as they reflect changing business trends, with positive revisions indicating analyst optimism about the company's profitability [4] - The Zacks Rank system currently rates Visa at 3 (Hold), with a Forward P/E ratio of 27.7, which is a premium compared to the industry's average Forward P/E of 12.99 [6] - Visa's PEG ratio stands at 2.14, higher than the Financial Transaction Services industry's average PEG ratio of 1.28 [7] Group 4: Industry Context - The Financial Transaction Services industry, which includes Visa, has a Zacks Industry Rank of 86, placing it in the top 35% of over 250 industries [7] - Research indicates that the top 50% rated industries outperform the bottom half by a factor of 2 to 1 [8]

Qualcomm (QCOM) closed at $129.72 in the latest trading session, marking a +1.77% move from the prior day. This change outpaced the S&P 500's 0.23% loss on the day. At the same time, the Dow lost 0.91%, and the tech-heavy Nasdaq gained 0.1%.Shares of the chipmaker witnessed a loss of 20.94% over the previous month, trailing the performance of the Computer and Technology sector with its loss of 16.18% and the S&P 500's loss of 12.13%.Market participants will be closely following the financial results of Qual ...

Core Viewpoint - The article compares Lloyds (LYG) and Canadian Imperial Bank (CM) to determine which stock is more attractive to value investors, highlighting the importance of valuation metrics and analyst outlooks in making investment decisions [1][3]. Valuation Metrics - Lloyds has a forward P/E ratio of 10.01, while Canadian Imperial Bank has a forward P/E of 10.53, indicating that Lloyds may be undervalued compared to its peer [5]. - The PEG ratio for Lloyds is 0.91, suggesting a favorable growth outlook relative to its earnings, whereas Canadian Imperial Bank has a PEG ratio of 1.30, indicating a less attractive growth valuation [5]. - Lloyds also has a P/B ratio of 0.95, compared to Canadian Imperial Bank's P/B of 1.40, further supporting the notion that Lloyds is undervalued [6]. Analyst Outlook - Lloyds currently holds a Zacks Rank of 2 (Buy), indicating a positive earnings estimate revision trend, while Canadian Imperial Bank has a Zacks Rank of 3 (Hold), suggesting a less favorable outlook [3]. - Based on the combination of valuation metrics and analyst ratings, Lloyds is positioned as the superior value option compared to Canadian Imperial Bank [6].

Investors looking for stocks in the Financial - Investment Bank sector might want to consider either BGC Group (BGC) or Tradeweb Markets (TW) . But which of these two stocks presents investors with the better value opportunity right now? Let's take a closer look.We have found that the best way to discover great value opportunities is to pair a strong Zacks Rank with a great grade in the Value category of our Style Scores system. The proven Zacks Rank puts an emphasis on earnings estimates and estimate revis ...

Group 1: Stock Performance - Dow Inc. closed at $34.89, marking a +0.81% move from the prior day, outperforming the S&P 500 which gained 0.67% [1] - Over the previous month, shares of Dow Inc. experienced a loss of 2.84%, underperforming the Basic Materials sector's gain of 0.34% and outperforming the S&P 500's loss of 5.28% [1] Group 2: Earnings Forecast - Dow Inc. is expected to release earnings on April 24, 2025, with a predicted EPS of $0.08, indicating an 85.71% decline compared to the same quarter last year [2] - The consensus estimate for revenue is $10.28 billion, down 4.53% from the prior-year quarter [2] Group 3: Full Year Estimates - For the full year, earnings are projected at $1.87 per share and revenue at $42.37 billion, reflecting changes of +9.36% and -1.38% respectively from the previous year [3] - Recent changes to analyst estimates for Dow Inc. may indicate shifting near-term business trends, with positive revisions seen as a good sign for the company's outlook [3][4] Group 4: Zacks Rank and Valuation - Dow Inc. currently holds a Zacks Rank of 5 (Strong Sell), with the consensus EPS projection moving 7.38% lower in the past 30 days [5] - The company is trading at a Forward P/E ratio of 18.49, which is a premium compared to the industry average Forward P/E of 13.77 [5] Group 5: PEG Ratio and Industry Ranking - Dow Inc. has a PEG ratio of 0.98, compared to the Chemical - Diversified industry's average PEG ratio of 1.07 [6] - The Chemical - Diversified industry ranks in the bottom 16% of all industries, with a current Zacks Industry Rank of 210 [6]

Core Viewpoint - Gilead Sciences is set to report its financial results on April 24, 2025, with significant expected growth in earnings per share (EPS) and revenue compared to the previous year [2][3]. Financial Performance - Gilead Sciences' stock closed at $111.88, reflecting a +0.54% change from the previous day, underperforming the S&P 500's gain of 0.67% [1] - The company is forecasted to report an EPS of $1.73, representing a 231.06% increase year-over-year [2] - Revenue is anticipated to be $6.8 billion, indicating a 1.67% increase from the same quarter last year [2] - Full-year estimates project earnings of $7.87 per share and revenue of $28.56 billion, showing year-over-year changes of +70.35% and -0.67%, respectively [3] Analyst Projections - Recent shifts in analyst projections for Gilead Sciences are important indicators of changing business trends, with positive revisions suggesting a favorable outlook [4] - The Zacks Consensus EPS estimate has increased by 0.16% over the last 30 days, and Gilead Sciences currently holds a Zacks Rank of 2 (Buy) [6] Valuation Metrics - Gilead Sciences has a Forward P/E ratio of 14.14, which is lower than the industry average of 17.2, indicating a potential undervaluation [7] - The company has a PEG ratio of 0.73, compared to the industry average of 1.41, suggesting that Gilead may be undervalued relative to its expected earnings growth [7] Industry Context - The Medical - Biomedical and Genetics industry, which includes Gilead Sciences, has a Zacks Industry Rank of 72, placing it in the top 29% of over 250 industries [8] - Strong industry rankings correlate with better stock performance, with the top 50% rated industries outperforming the bottom half by a factor of 2 to 1 [8]

Company Performance - Walmart's stock closed at $89.76, reflecting a +1.05% increase from the previous day, outperforming the S&P 500's gain of 0.67% [1] - Over the past month, Walmart's stock has decreased by 6.47%, which is better than the Retail-Wholesale sector's decline of 6.91% but worse than the S&P 500's loss of 5.28% [1] Upcoming Earnings - Walmart is expected to report earnings of $0.59 per share, indicating a year-over-year decline of 1.67%, with projected revenue of $165.92 billion, representing a 2.73% growth compared to the same quarter last year [2] - For the entire fiscal year, earnings are estimated at $2.63 per share and revenue at $703.77 billion, reflecting increases of +4.78% and +3.35% respectively from the previous year [3] Analyst Estimates - Recent changes in analyst estimates for Walmart suggest a favorable outlook on the company's business health and profitability [4] - The consensus EPS projection has decreased by 0.21% in the past 30 days, and Walmart currently holds a Zacks Rank of 3 (Hold) [6] Valuation Metrics - Walmart is trading with a Forward P/E ratio of 33.81, significantly higher than the industry average of 13.07, indicating a premium valuation [7] - The company has a PEG ratio of 4.72, compared to the Retail - Supermarkets industry average PEG ratio of 2.18, suggesting a higher expected earnings growth trajectory relative to its price [8] Industry Context - The Retail - Supermarkets industry, part of the Retail-Wholesale sector, has a Zacks Industry Rank of 149, placing it in the bottom 41% of over 250 industries [9]

Core Insights - Investors in the Electronics - Miscellaneous Products sector should consider Hayward Holdings, Inc. (HAYW) and Teradyne (TER) for potential value opportunities [1] Valuation Metrics - HAYW has a Zacks Rank of 2 (Buy), indicating a positive earnings outlook, while TER has a Zacks Rank of 5 (Strong Sell) [3] - HAYW's forward P/E ratio is 18.73, compared to TER's forward P/E of 24.46, suggesting HAYW is more attractively priced [5] - HAYW has a PEG ratio of 2.19, while TER's PEG ratio is 3.66, indicating HAYW's expected EPS growth is more favorable [5] - HAYW's P/B ratio is 2.07, significantly lower than TER's P/B of 4.77, further supporting HAYW's valuation advantage [6] - HAYW has a Value grade of B, while TER has a Value grade of F, highlighting HAYW's stronger valuation metrics [6] Conclusion - Given the stronger estimate revision activity and more attractive valuation metrics, HAYW is positioned as the superior option for value investors compared to TER [7]